search
Divergence Labs
Trends
- 1IgE disruptor for food allergy designed using Claude●IgE disruptor for food allergy with Claude-enabled antibody design [pdf]
A preprint from Divergence Labs describes an IgE disruptor therapy for food allergy, with antibody design reportedly assisted by Claude. If the results hold up, it would point to a new approach to preventing allergic reactions by targeting IgE, and a concrete example of AI language models contributing to drug design rather than just text work.
- 2OpenAI's 'Trillion AIs' vision as Anthropic goes public●AI: OpenAI’s ‘Trillion AIs’ Future, as Anthropic Goes Public. AI-RTZ #1257
A commentary from AI-Reset to Zero argues OpenAI is steering toward a future of a trillion AI agents, while Anthropic moves into public markets. The piece frames the two leading AI labs as taking diverging paths: OpenAI pursuing massive-scale deployment, Anthropic embracing public listing. No further details on funding figures or timelines are given.